Receive a FREE Mesothelioma Treatment
Information Packet

Mesothelioma

Phase I Study of Patients With Advanced or Recurrent Malignancy

Phase I Study of Intraperitoneal PV701 in Patients With Advanced or Recurrent Malignancy Largely Confined to the Peritoneal Cavity

Background:
PV701 may be able to kill tumor cells while leaving normal cells undamaged. This is a Phase I trial to study the effectiveness of PV701 in treating patients who have advanced or recurrent ovarian epithelial, fallopian tube, primary peritoneal, colorectal, or other cancer within the peritoneal cavity.
Memorial Sloan-Kettering Cancer Center
Owen A. O'Connor, MD, PhD, Protocol Chair
Ph: 212-639-8889

Location/Contacts:
New York
New York
Memorial Sloan-Kettering Cancer Center
Leonard Bruce Saltz, MD
Ph: 212-639-2501

Owen A. O'Connor, MD, PhD
Ph: 212-639-8889